nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP3A5—prostate cancer	0.183	0.474	CbGaD
Granisetron—CYP1A1—prostate cancer	0.124	0.321	CbGaD
Granisetron—CYP3A4—prostate cancer	0.079	0.205	CbGaD
Granisetron—CYP1A1—Flutamide—prostate cancer	0.0529	0.131	CbGbCtD
Granisetron—CYP1A1—Estrone—prostate cancer	0.0382	0.0944	CbGbCtD
Granisetron—CYP3A5—Flutamide—prostate cancer	0.0317	0.0784	CbGbCtD
Granisetron—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0284	0.0702	CbGbCtD
Granisetron—CYP2D6—Bicalutamide—prostate cancer	0.0235	0.058	CbGbCtD
Granisetron—CYP3A5—Cabazitaxel—prostate cancer	0.0235	0.058	CbGbCtD
Granisetron—CYP3A5—Estrone—prostate cancer	0.0229	0.0567	CbGbCtD
Granisetron—CYP1A1—Estradiol—prostate cancer	0.022	0.0542	CbGbCtD
Granisetron—CYP2D6—Abiraterone—prostate cancer	0.0195	0.0481	CbGbCtD
Granisetron—CYP3A4—Bicalutamide—prostate cancer	0.0149	0.0369	CbGbCtD
Granisetron—CYP3A4—Estramustine—prostate cancer	0.0139	0.0343	CbGbCtD
Granisetron—CYP3A5—Estradiol—prostate cancer	0.0132	0.0325	CbGbCtD
Granisetron—CYP3A4—Abiraterone—prostate cancer	0.0124	0.0306	CbGbCtD
Granisetron—CYP3A4—Flutamide—prostate cancer	0.0124	0.0306	CbGbCtD
Granisetron—CYP3A4—Cabazitaxel—prostate cancer	0.00915	0.0226	CbGbCtD
Granisetron—CYP3A4—Estrone—prostate cancer	0.00895	0.0221	CbGbCtD
Granisetron—CYP3A5—Etoposide—prostate cancer	0.0086	0.0213	CbGbCtD
Granisetron—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00797	0.0197	CbGbCtD
Granisetron—CYP3A5—Docetaxel—prostate cancer	0.00787	0.0194	CbGbCtD
Granisetron—CYP3A4—Conjugated Estrogens—prostate cancer	0.00585	0.0145	CbGbCtD
Granisetron—CYP3A4—Mitoxantrone—prostate cancer	0.00532	0.0131	CbGbCtD
Granisetron—CYP3A4—Estradiol—prostate cancer	0.00514	0.0127	CbGbCtD
Granisetron—CYP3A4—Prednisone—prostate cancer	0.00442	0.0109	CbGbCtD
Granisetron—CYP2D6—Doxorubicin—prostate cancer	0.0036	0.00889	CbGbCtD
Granisetron—CYP3A4—Etoposide—prostate cancer	0.00336	0.00829	CbGbCtD
Granisetron—CYP3A4—Docetaxel—prostate cancer	0.00307	0.00758	CbGbCtD
Granisetron—CYP3A4—Doxorubicin—prostate cancer	0.00229	0.00565	CbGbCtD
Granisetron—Urticaria—Etoposide—prostate cancer	4.99e-05	0.000365	CcSEcCtD
Granisetron—Jaundice—Doxorubicin—prostate cancer	4.98e-05	0.000364	CcSEcCtD
Granisetron—Malaise—Prednisone—prostate cancer	4.98e-05	0.000364	CcSEcCtD
Granisetron—Shock—Capecitabine—prostate cancer	4.98e-05	0.000363	CcSEcCtD
Granisetron—Rhinitis—Epirubicin—prostate cancer	4.97e-05	0.000363	CcSEcCtD
Granisetron—Body temperature increased—Etoposide—prostate cancer	4.97e-05	0.000363	CcSEcCtD
Granisetron—Abdominal pain—Etoposide—prostate cancer	4.97e-05	0.000363	CcSEcCtD
Granisetron—Urinary tract infection—Doxorubicin—prostate cancer	4.97e-05	0.000363	CcSEcCtD
Granisetron—Nervous system disorder—Capecitabine—prostate cancer	4.96e-05	0.000362	CcSEcCtD
Granisetron—Vertigo—Prednisone—prostate cancer	4.96e-05	0.000362	CcSEcCtD
Granisetron—Thrombocytopenia—Capecitabine—prostate cancer	4.95e-05	0.000362	CcSEcCtD
Granisetron—Syncope—Prednisone—prostate cancer	4.95e-05	0.000362	CcSEcCtD
Granisetron—Tachycardia—Capecitabine—prostate cancer	4.94e-05	0.000361	CcSEcCtD
Granisetron—Skin disorder—Capecitabine—prostate cancer	4.91e-05	0.000359	CcSEcCtD
Granisetron—Sweating—Doxorubicin—prostate cancer	4.9e-05	0.000358	CcSEcCtD
Granisetron—Hyperhidrosis—Capecitabine—prostate cancer	4.89e-05	0.000357	CcSEcCtD
Granisetron—Hypotension—Docetaxel—prostate cancer	4.88e-05	0.000357	CcSEcCtD
Granisetron—Connective tissue disorder—Epirubicin—prostate cancer	4.87e-05	0.000356	CcSEcCtD
Granisetron—Loss of consciousness—Prednisone—prostate cancer	4.85e-05	0.000354	CcSEcCtD
Granisetron—Hepatobiliary disease—Doxorubicin—prostate cancer	4.83e-05	0.000353	CcSEcCtD
Granisetron—Epistaxis—Doxorubicin—prostate cancer	4.82e-05	0.000352	CcSEcCtD
Granisetron—Nausea—Estradiol—prostate cancer	4.82e-05	0.000352	CcSEcCtD
Granisetron—Vomiting—Mitoxantrone—prostate cancer	4.8e-05	0.000351	CcSEcCtD
Granisetron—Sinusitis—Doxorubicin—prostate cancer	4.8e-05	0.00035	CcSEcCtD
Granisetron—Visual impairment—Epirubicin—prostate cancer	4.78e-05	0.000349	CcSEcCtD
Granisetron—Hypertension—Prednisone—prostate cancer	4.77e-05	0.000348	CcSEcCtD
Granisetron—Rash—Mitoxantrone—prostate cancer	4.76e-05	0.000348	CcSEcCtD
Granisetron—Dermatitis—Mitoxantrone—prostate cancer	4.76e-05	0.000348	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.76e-05	0.000348	CcSEcCtD
Granisetron—Headache—Mitoxantrone—prostate cancer	4.73e-05	0.000346	CcSEcCtD
Granisetron—Hypotension—Capecitabine—prostate cancer	4.73e-05	0.000345	CcSEcCtD
Granisetron—Insomnia—Docetaxel—prostate cancer	4.72e-05	0.000345	CcSEcCtD
Granisetron—Arthralgia—Prednisone—prostate cancer	4.7e-05	0.000343	CcSEcCtD
Granisetron—Paraesthesia—Docetaxel—prostate cancer	4.69e-05	0.000343	CcSEcCtD
Granisetron—Anxiety—Prednisone—prostate cancer	4.68e-05	0.000342	CcSEcCtD
Granisetron—Bradycardia—Doxorubicin—prostate cancer	4.67e-05	0.000341	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.67e-05	0.000341	CcSEcCtD
Granisetron—Dyspnoea—Docetaxel—prostate cancer	4.66e-05	0.00034	CcSEcCtD
Granisetron—Somnolence—Docetaxel—prostate cancer	4.64e-05	0.000339	CcSEcCtD
Granisetron—Discomfort—Prednisone—prostate cancer	4.64e-05	0.000339	CcSEcCtD
Granisetron—Hypersensitivity—Etoposide—prostate cancer	4.63e-05	0.000338	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.61e-05	0.000337	CcSEcCtD
Granisetron—Flushing—Epirubicin—prostate cancer	4.6e-05	0.000336	CcSEcCtD
Granisetron—Rhinitis—Doxorubicin—prostate cancer	4.6e-05	0.000336	CcSEcCtD
Granisetron—Dyspepsia—Docetaxel—prostate cancer	4.6e-05	0.000336	CcSEcCtD
Granisetron—Insomnia—Capecitabine—prostate cancer	4.57e-05	0.000334	CcSEcCtD
Granisetron—Paraesthesia—Capecitabine—prostate cancer	4.54e-05	0.000332	CcSEcCtD
Granisetron—Decreased appetite—Docetaxel—prostate cancer	4.54e-05	0.000332	CcSEcCtD
Granisetron—Gastrointestinal disorder—Docetaxel—prostate cancer	4.51e-05	0.000329	CcSEcCtD
Granisetron—Asthenia—Etoposide—prostate cancer	4.51e-05	0.000329	CcSEcCtD
Granisetron—Connective tissue disorder—Doxorubicin—prostate cancer	4.51e-05	0.000329	CcSEcCtD
Granisetron—Dyspnoea—Capecitabine—prostate cancer	4.51e-05	0.000329	CcSEcCtD
Granisetron—Anaphylactic shock—Prednisone—prostate cancer	4.51e-05	0.000329	CcSEcCtD
Granisetron—Oedema—Prednisone—prostate cancer	4.51e-05	0.000329	CcSEcCtD
Granisetron—Angiopathy—Epirubicin—prostate cancer	4.5e-05	0.000329	CcSEcCtD
Granisetron—Nausea—Mitoxantrone—prostate cancer	4.49e-05	0.000328	CcSEcCtD
Granisetron—Infection—Prednisone—prostate cancer	4.48e-05	0.000327	CcSEcCtD
Granisetron—Pain—Docetaxel—prostate cancer	4.47e-05	0.000326	CcSEcCtD
Granisetron—Constipation—Docetaxel—prostate cancer	4.47e-05	0.000326	CcSEcCtD
Granisetron—Dyspepsia—Capecitabine—prostate cancer	4.45e-05	0.000325	CcSEcCtD
Granisetron—Chills—Epirubicin—prostate cancer	4.45e-05	0.000325	CcSEcCtD
Granisetron—Pruritus—Etoposide—prostate cancer	4.45e-05	0.000325	CcSEcCtD
Granisetron—Shock—Prednisone—prostate cancer	4.43e-05	0.000324	CcSEcCtD
Granisetron—Arrhythmia—Epirubicin—prostate cancer	4.43e-05	0.000324	CcSEcCtD
Granisetron—Visual impairment—Doxorubicin—prostate cancer	4.42e-05	0.000323	CcSEcCtD
Granisetron—Nervous system disorder—Prednisone—prostate cancer	4.42e-05	0.000323	CcSEcCtD
Granisetron—Tachycardia—Prednisone—prostate cancer	4.4e-05	0.000321	CcSEcCtD
Granisetron—Decreased appetite—Capecitabine—prostate cancer	4.4e-05	0.000321	CcSEcCtD
Granisetron—Alopecia—Epirubicin—prostate cancer	4.38e-05	0.00032	CcSEcCtD
Granisetron—Skin disorder—Prednisone—prostate cancer	4.38e-05	0.00032	CcSEcCtD
Granisetron—Gastrointestinal disorder—Capecitabine—prostate cancer	4.37e-05	0.000319	CcSEcCtD
Granisetron—Hyperhidrosis—Prednisone—prostate cancer	4.36e-05	0.000318	CcSEcCtD
Granisetron—Pain—Capecitabine—prostate cancer	4.33e-05	0.000316	CcSEcCtD
Granisetron—Constipation—Capecitabine—prostate cancer	4.33e-05	0.000316	CcSEcCtD
Granisetron—Malnutrition—Epirubicin—prostate cancer	4.32e-05	0.000315	CcSEcCtD
Granisetron—Feeling abnormal—Docetaxel—prostate cancer	4.3e-05	0.000314	CcSEcCtD
Granisetron—Diarrhoea—Etoposide—prostate cancer	4.3e-05	0.000314	CcSEcCtD
Granisetron—Gastrointestinal pain—Docetaxel—prostate cancer	4.27e-05	0.000312	CcSEcCtD
Granisetron—Flushing—Doxorubicin—prostate cancer	4.26e-05	0.000311	CcSEcCtD
Granisetron—Flatulence—Epirubicin—prostate cancer	4.25e-05	0.000311	CcSEcCtD
Granisetron—Tension—Epirubicin—prostate cancer	4.24e-05	0.000309	CcSEcCtD
Granisetron—Dysgeusia—Epirubicin—prostate cancer	4.23e-05	0.000309	CcSEcCtD
Granisetron—Nervousness—Epirubicin—prostate cancer	4.19e-05	0.000306	CcSEcCtD
Granisetron—Feeling abnormal—Capecitabine—prostate cancer	4.17e-05	0.000304	CcSEcCtD
Granisetron—Angiopathy—Doxorubicin—prostate cancer	4.16e-05	0.000304	CcSEcCtD
Granisetron—Dizziness—Etoposide—prostate cancer	4.16e-05	0.000304	CcSEcCtD
Granisetron—Gastrointestinal pain—Capecitabine—prostate cancer	4.14e-05	0.000302	CcSEcCtD
Granisetron—Abdominal pain—Docetaxel—prostate cancer	4.13e-05	0.000302	CcSEcCtD
Granisetron—Body temperature increased—Docetaxel—prostate cancer	4.13e-05	0.000302	CcSEcCtD
Granisetron—Chills—Doxorubicin—prostate cancer	4.12e-05	0.000301	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Prednisone—prostate cancer	4.1e-05	0.0003	CcSEcCtD
Granisetron—Arrhythmia—Doxorubicin—prostate cancer	4.1e-05	0.000299	CcSEcCtD
Granisetron—Insomnia—Prednisone—prostate cancer	4.07e-05	0.000298	CcSEcCtD
Granisetron—Alopecia—Doxorubicin—prostate cancer	4.06e-05	0.000296	CcSEcCtD
Granisetron—Paraesthesia—Prednisone—prostate cancer	4.05e-05	0.000296	CcSEcCtD
Granisetron—Urticaria—Capecitabine—prostate cancer	4.02e-05	0.000293	CcSEcCtD
Granisetron—Ill-defined disorder—Epirubicin—prostate cancer	4.01e-05	0.000293	CcSEcCtD
Granisetron—Body temperature increased—Capecitabine—prostate cancer	4e-05	0.000292	CcSEcCtD
Granisetron—Abdominal pain—Capecitabine—prostate cancer	4e-05	0.000292	CcSEcCtD
Granisetron—Vomiting—Etoposide—prostate cancer	4e-05	0.000292	CcSEcCtD
Granisetron—Malnutrition—Doxorubicin—prostate cancer	3.99e-05	0.000292	CcSEcCtD
Granisetron—Anaemia—Epirubicin—prostate cancer	3.99e-05	0.000291	CcSEcCtD
Granisetron—Agitation—Epirubicin—prostate cancer	3.97e-05	0.00029	CcSEcCtD
Granisetron—Dyspepsia—Prednisone—prostate cancer	3.97e-05	0.00029	CcSEcCtD
Granisetron—Rash—Etoposide—prostate cancer	3.96e-05	0.00029	CcSEcCtD
Granisetron—Dermatitis—Etoposide—prostate cancer	3.96e-05	0.000289	CcSEcCtD
Granisetron—Headache—Etoposide—prostate cancer	3.94e-05	0.000288	CcSEcCtD
Granisetron—Flatulence—Doxorubicin—prostate cancer	3.94e-05	0.000288	CcSEcCtD
Granisetron—Tension—Doxorubicin—prostate cancer	3.92e-05	0.000286	CcSEcCtD
Granisetron—Decreased appetite—Prednisone—prostate cancer	3.92e-05	0.000286	CcSEcCtD
Granisetron—Dysgeusia—Doxorubicin—prostate cancer	3.91e-05	0.000286	CcSEcCtD
Granisetron—Malaise—Epirubicin—prostate cancer	3.89e-05	0.000284	CcSEcCtD
Granisetron—Nervousness—Doxorubicin—prostate cancer	3.88e-05	0.000283	CcSEcCtD
Granisetron—Vertigo—Epirubicin—prostate cancer	3.88e-05	0.000283	CcSEcCtD
Granisetron—Syncope—Epirubicin—prostate cancer	3.87e-05	0.000283	CcSEcCtD
Granisetron—Leukopenia—Epirubicin—prostate cancer	3.86e-05	0.000282	CcSEcCtD
Granisetron—Constipation—Prednisone—prostate cancer	3.85e-05	0.000281	CcSEcCtD
Granisetron—Hypersensitivity—Docetaxel—prostate cancer	3.85e-05	0.000281	CcSEcCtD
Granisetron—Palpitations—Epirubicin—prostate cancer	3.82e-05	0.000279	CcSEcCtD
Granisetron—Loss of consciousness—Epirubicin—prostate cancer	3.79e-05	0.000277	CcSEcCtD
Granisetron—Cough—Epirubicin—prostate cancer	3.77e-05	0.000275	CcSEcCtD
Granisetron—Asthenia—Docetaxel—prostate cancer	3.75e-05	0.000274	CcSEcCtD
Granisetron—Nausea—Etoposide—prostate cancer	3.73e-05	0.000273	CcSEcCtD
Granisetron—Hypertension—Epirubicin—prostate cancer	3.73e-05	0.000272	CcSEcCtD
Granisetron—Hypersensitivity—Capecitabine—prostate cancer	3.73e-05	0.000272	CcSEcCtD
Granisetron—Feeling abnormal—Prednisone—prostate cancer	3.71e-05	0.000271	CcSEcCtD
Granisetron—Ill-defined disorder—Doxorubicin—prostate cancer	3.71e-05	0.000271	CcSEcCtD
Granisetron—Pruritus—Docetaxel—prostate cancer	3.7e-05	0.00027	CcSEcCtD
Granisetron—Anaemia—Doxorubicin—prostate cancer	3.69e-05	0.00027	CcSEcCtD
Granisetron—Gastrointestinal pain—Prednisone—prostate cancer	3.68e-05	0.000269	CcSEcCtD
Granisetron—Arthralgia—Epirubicin—prostate cancer	3.68e-05	0.000268	CcSEcCtD
Granisetron—Chest pain—Epirubicin—prostate cancer	3.68e-05	0.000268	CcSEcCtD
Granisetron—Agitation—Doxorubicin—prostate cancer	3.67e-05	0.000268	CcSEcCtD
Granisetron—Anxiety—Epirubicin—prostate cancer	3.66e-05	0.000268	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.65e-05	0.000267	CcSEcCtD
Granisetron—Discomfort—Epirubicin—prostate cancer	3.63e-05	0.000265	CcSEcCtD
Granisetron—Asthenia—Capecitabine—prostate cancer	3.63e-05	0.000265	CcSEcCtD
Granisetron—Malaise—Doxorubicin—prostate cancer	3.6e-05	0.000263	CcSEcCtD
Granisetron—Dry mouth—Epirubicin—prostate cancer	3.59e-05	0.000263	CcSEcCtD
Granisetron—Vertigo—Doxorubicin—prostate cancer	3.59e-05	0.000262	CcSEcCtD
Granisetron—Syncope—Doxorubicin—prostate cancer	3.58e-05	0.000262	CcSEcCtD
Granisetron—Urticaria—Prednisone—prostate cancer	3.58e-05	0.000261	CcSEcCtD
Granisetron—Pruritus—Capecitabine—prostate cancer	3.58e-05	0.000261	CcSEcCtD
Granisetron—Leukopenia—Doxorubicin—prostate cancer	3.58e-05	0.000261	CcSEcCtD
Granisetron—Diarrhoea—Docetaxel—prostate cancer	3.57e-05	0.000261	CcSEcCtD
Granisetron—Body temperature increased—Prednisone—prostate cancer	3.56e-05	0.00026	CcSEcCtD
Granisetron—Abdominal pain—Prednisone—prostate cancer	3.56e-05	0.00026	CcSEcCtD
Granisetron—Palpitations—Doxorubicin—prostate cancer	3.53e-05	0.000258	CcSEcCtD
Granisetron—Oedema—Epirubicin—prostate cancer	3.52e-05	0.000257	CcSEcCtD
Granisetron—Anaphylactic shock—Epirubicin—prostate cancer	3.52e-05	0.000257	CcSEcCtD
Granisetron—Loss of consciousness—Doxorubicin—prostate cancer	3.51e-05	0.000256	CcSEcCtD
Granisetron—Infection—Epirubicin—prostate cancer	3.5e-05	0.000256	CcSEcCtD
Granisetron—Cough—Doxorubicin—prostate cancer	3.49e-05	0.000255	CcSEcCtD
Granisetron—Shock—Epirubicin—prostate cancer	3.47e-05	0.000253	CcSEcCtD
Granisetron—Diarrhoea—Capecitabine—prostate cancer	3.46e-05	0.000253	CcSEcCtD
Granisetron—Nervous system disorder—Epirubicin—prostate cancer	3.46e-05	0.000252	CcSEcCtD
Granisetron—Dizziness—Docetaxel—prostate cancer	3.45e-05	0.000252	CcSEcCtD
Granisetron—Thrombocytopenia—Epirubicin—prostate cancer	3.45e-05	0.000252	CcSEcCtD
Granisetron—Hypertension—Doxorubicin—prostate cancer	3.45e-05	0.000252	CcSEcCtD
Granisetron—Tachycardia—Epirubicin—prostate cancer	3.44e-05	0.000251	CcSEcCtD
Granisetron—Skin disorder—Epirubicin—prostate cancer	3.42e-05	0.00025	CcSEcCtD
Granisetron—Hyperhidrosis—Epirubicin—prostate cancer	3.41e-05	0.000249	CcSEcCtD
Granisetron—Arthralgia—Doxorubicin—prostate cancer	3.4e-05	0.000248	CcSEcCtD
Granisetron—Chest pain—Doxorubicin—prostate cancer	3.4e-05	0.000248	CcSEcCtD
Granisetron—Anxiety—Doxorubicin—prostate cancer	3.39e-05	0.000248	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.38e-05	0.000247	CcSEcCtD
Granisetron—Discomfort—Doxorubicin—prostate cancer	3.36e-05	0.000245	CcSEcCtD
Granisetron—Dizziness—Capecitabine—prostate cancer	3.34e-05	0.000244	CcSEcCtD
Granisetron—Dry mouth—Doxorubicin—prostate cancer	3.33e-05	0.000243	CcSEcCtD
Granisetron—Vomiting—Docetaxel—prostate cancer	3.32e-05	0.000243	CcSEcCtD
Granisetron—Hypersensitivity—Prednisone—prostate cancer	3.32e-05	0.000242	CcSEcCtD
Granisetron—Rash—Docetaxel—prostate cancer	3.29e-05	0.000241	CcSEcCtD
Granisetron—Hypotension—Epirubicin—prostate cancer	3.29e-05	0.000241	CcSEcCtD
Granisetron—Dermatitis—Docetaxel—prostate cancer	3.29e-05	0.00024	CcSEcCtD
Granisetron—Headache—Docetaxel—prostate cancer	3.27e-05	0.000239	CcSEcCtD
Granisetron—Anaphylactic shock—Doxorubicin—prostate cancer	3.26e-05	0.000238	CcSEcCtD
Granisetron—Oedema—Doxorubicin—prostate cancer	3.26e-05	0.000238	CcSEcCtD
Granisetron—Infection—Doxorubicin—prostate cancer	3.24e-05	0.000237	CcSEcCtD
Granisetron—Asthenia—Prednisone—prostate cancer	3.23e-05	0.000236	CcSEcCtD
Granisetron—Vomiting—Capecitabine—prostate cancer	3.22e-05	0.000235	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.21e-05	0.000234	CcSEcCtD
Granisetron—Shock—Doxorubicin—prostate cancer	3.21e-05	0.000234	CcSEcCtD
Granisetron—Nervous system disorder—Doxorubicin—prostate cancer	3.2e-05	0.000234	CcSEcCtD
Granisetron—Thrombocytopenia—Doxorubicin—prostate cancer	3.19e-05	0.000233	CcSEcCtD
Granisetron—Rash—Capecitabine—prostate cancer	3.19e-05	0.000233	CcSEcCtD
Granisetron—Pruritus—Prednisone—prostate cancer	3.19e-05	0.000233	CcSEcCtD
Granisetron—Insomnia—Epirubicin—prostate cancer	3.19e-05	0.000233	CcSEcCtD
Granisetron—Dermatitis—Capecitabine—prostate cancer	3.19e-05	0.000233	CcSEcCtD
Granisetron—Tachycardia—Doxorubicin—prostate cancer	3.18e-05	0.000232	CcSEcCtD
Granisetron—Headache—Capecitabine—prostate cancer	3.17e-05	0.000231	CcSEcCtD
Granisetron—Skin disorder—Doxorubicin—prostate cancer	3.17e-05	0.000231	CcSEcCtD
Granisetron—Paraesthesia—Epirubicin—prostate cancer	3.16e-05	0.000231	CcSEcCtD
Granisetron—Hyperhidrosis—Doxorubicin—prostate cancer	3.15e-05	0.00023	CcSEcCtD
Granisetron—Dyspnoea—Epirubicin—prostate cancer	3.14e-05	0.000229	CcSEcCtD
Granisetron—Somnolence—Epirubicin—prostate cancer	3.13e-05	0.000229	CcSEcCtD
Granisetron—Nausea—Docetaxel—prostate cancer	3.1e-05	0.000227	CcSEcCtD
Granisetron—Dyspepsia—Epirubicin—prostate cancer	3.1e-05	0.000227	CcSEcCtD
Granisetron—Diarrhoea—Prednisone—prostate cancer	3.08e-05	0.000225	CcSEcCtD
Granisetron—Decreased appetite—Epirubicin—prostate cancer	3.06e-05	0.000224	CcSEcCtD
Granisetron—Hypotension—Doxorubicin—prostate cancer	3.05e-05	0.000223	CcSEcCtD
Granisetron—Gastrointestinal disorder—Epirubicin—prostate cancer	3.04e-05	0.000222	CcSEcCtD
Granisetron—Pain—Epirubicin—prostate cancer	3.01e-05	0.00022	CcSEcCtD
Granisetron—Constipation—Epirubicin—prostate cancer	3.01e-05	0.00022	CcSEcCtD
Granisetron—Nausea—Capecitabine—prostate cancer	3e-05	0.000219	CcSEcCtD
Granisetron—Dizziness—Prednisone—prostate cancer	2.98e-05	0.000218	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.97e-05	0.000217	CcSEcCtD
Granisetron—Insomnia—Doxorubicin—prostate cancer	2.95e-05	0.000215	CcSEcCtD
Granisetron—Paraesthesia—Doxorubicin—prostate cancer	2.93e-05	0.000214	CcSEcCtD
Granisetron—Dyspnoea—Doxorubicin—prostate cancer	2.91e-05	0.000212	CcSEcCtD
Granisetron—Feeling abnormal—Epirubicin—prostate cancer	2.9e-05	0.000212	CcSEcCtD
Granisetron—Somnolence—Doxorubicin—prostate cancer	2.9e-05	0.000212	CcSEcCtD
Granisetron—Gastrointestinal pain—Epirubicin—prostate cancer	2.88e-05	0.00021	CcSEcCtD
Granisetron—Dyspepsia—Doxorubicin—prostate cancer	2.87e-05	0.00021	CcSEcCtD
Granisetron—Vomiting—Prednisone—prostate cancer	2.86e-05	0.000209	CcSEcCtD
Granisetron—Rash—Prednisone—prostate cancer	2.84e-05	0.000207	CcSEcCtD
Granisetron—Dermatitis—Prednisone—prostate cancer	2.84e-05	0.000207	CcSEcCtD
Granisetron—Decreased appetite—Doxorubicin—prostate cancer	2.83e-05	0.000207	CcSEcCtD
Granisetron—Headache—Prednisone—prostate cancer	2.82e-05	0.000206	CcSEcCtD
Granisetron—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.81e-05	0.000206	CcSEcCtD
Granisetron—Urticaria—Epirubicin—prostate cancer	2.8e-05	0.000204	CcSEcCtD
Granisetron—Pain—Doxorubicin—prostate cancer	2.79e-05	0.000204	CcSEcCtD
Granisetron—Constipation—Doxorubicin—prostate cancer	2.79e-05	0.000204	CcSEcCtD
Granisetron—Body temperature increased—Epirubicin—prostate cancer	2.79e-05	0.000203	CcSEcCtD
Granisetron—Abdominal pain—Epirubicin—prostate cancer	2.79e-05	0.000203	CcSEcCtD
Granisetron—Feeling abnormal—Doxorubicin—prostate cancer	2.69e-05	0.000196	CcSEcCtD
Granisetron—Nausea—Prednisone—prostate cancer	2.68e-05	0.000195	CcSEcCtD
Granisetron—Gastrointestinal pain—Doxorubicin—prostate cancer	2.67e-05	0.000195	CcSEcCtD
Granisetron—Hypersensitivity—Epirubicin—prostate cancer	2.6e-05	0.00019	CcSEcCtD
Granisetron—Urticaria—Doxorubicin—prostate cancer	2.59e-05	0.000189	CcSEcCtD
Granisetron—Body temperature increased—Doxorubicin—prostate cancer	2.58e-05	0.000188	CcSEcCtD
Granisetron—Abdominal pain—Doxorubicin—prostate cancer	2.58e-05	0.000188	CcSEcCtD
Granisetron—Asthenia—Epirubicin—prostate cancer	2.53e-05	0.000185	CcSEcCtD
Granisetron—Pruritus—Epirubicin—prostate cancer	2.49e-05	0.000182	CcSEcCtD
Granisetron—Diarrhoea—Epirubicin—prostate cancer	2.41e-05	0.000176	CcSEcCtD
Granisetron—Hypersensitivity—Doxorubicin—prostate cancer	2.4e-05	0.000175	CcSEcCtD
Granisetron—Asthenia—Doxorubicin—prostate cancer	2.34e-05	0.000171	CcSEcCtD
Granisetron—Dizziness—Epirubicin—prostate cancer	2.33e-05	0.00017	CcSEcCtD
Granisetron—Pruritus—Doxorubicin—prostate cancer	2.31e-05	0.000168	CcSEcCtD
Granisetron—Vomiting—Epirubicin—prostate cancer	2.24e-05	0.000164	CcSEcCtD
Granisetron—Diarrhoea—Doxorubicin—prostate cancer	2.23e-05	0.000163	CcSEcCtD
Granisetron—Rash—Epirubicin—prostate cancer	2.22e-05	0.000162	CcSEcCtD
Granisetron—Dermatitis—Epirubicin—prostate cancer	2.22e-05	0.000162	CcSEcCtD
Granisetron—Headache—Epirubicin—prostate cancer	2.21e-05	0.000161	CcSEcCtD
Granisetron—Dizziness—Doxorubicin—prostate cancer	2.16e-05	0.000157	CcSEcCtD
Granisetron—Nausea—Epirubicin—prostate cancer	2.09e-05	0.000153	CcSEcCtD
Granisetron—Vomiting—Doxorubicin—prostate cancer	2.07e-05	0.000151	CcSEcCtD
Granisetron—Rash—Doxorubicin—prostate cancer	2.06e-05	0.00015	CcSEcCtD
Granisetron—Dermatitis—Doxorubicin—prostate cancer	2.05e-05	0.00015	CcSEcCtD
Granisetron—Headache—Doxorubicin—prostate cancer	2.04e-05	0.000149	CcSEcCtD
Granisetron—Nausea—Doxorubicin—prostate cancer	1.94e-05	0.000141	CcSEcCtD
Granisetron—CYP1A1—Metabolism—P4HB—prostate cancer	8.02e-06	0.00011	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—LDHB—prostate cancer	7.97e-06	0.000109	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—MED12—prostate cancer	7.92e-06	0.000109	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GNG5—prostate cancer	7.86e-06	0.000108	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP3A5—prostate cancer	7.82e-06	0.000107	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC22A1—prostate cancer	7.81e-06	0.000107	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	7.72e-06	0.000106	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—AMACR—prostate cancer	7.66e-06	0.000105	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP3A43—prostate cancer	7.66e-06	0.000105	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NAT1—prostate cancer	7.66e-06	0.000105	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—DEGS1—prostate cancer	7.66e-06	0.000105	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SRD5A2—prostate cancer	7.66e-06	0.000105	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SULT2A1—prostate cancer	7.61e-06	0.000104	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NCOA3—prostate cancer	7.57e-06	0.000104	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PDHA1—prostate cancer	7.55e-06	0.000104	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—UCP3—prostate cancer	7.55e-06	0.000104	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTA3—prostate cancer	7.55e-06	0.000104	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—TCN2—prostate cancer	7.55e-06	0.000104	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—MED12—prostate cancer	7.48e-06	0.000103	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GNG5—prostate cancer	7.42e-06	0.000102	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HSD17B1—prostate cancer	7.31e-06	0.0001	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HPGDS—prostate cancer	7.22e-06	9.9e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC22A3—prostate cancer	7.21e-06	9.88e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HSD3B1—prostate cancer	7.21e-06	9.88e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP2C19—prostate cancer	7.18e-06	9.84e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NCOA3—prostate cancer	7.15e-06	9.81e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7.03e-06	9.64e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTT1—prostate cancer	7e-06	9.6e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ACHE—prostate cancer	7e-06	9.6e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP2A6—prostate cancer	6.92e-06	9.49e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTA4—prostate cancer	6.91e-06	9.47e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—TBXAS1—prostate cancer	6.91e-06	9.47e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—HPGDS—prostate cancer	6.82e-06	9.36e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP2C19—prostate cancer	6.78e-06	9.3e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—AKR1C3—prostate cancer	6.74e-06	9.24e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTA2—prostate cancer	6.73e-06	9.23e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PRKACB—prostate cancer	6.7e-06	9.19e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ABCG5—prostate cancer	6.65e-06	9.12e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SULT1A1—prostate cancer	6.65e-06	9.12e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP17A1—prostate cancer	6.63e-06	9.09e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTT1—prostate cancer	6.62e-06	9.07e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ACHE—prostate cancer	6.62e-06	9.07e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP2A6—prostate cancer	6.54e-06	8.97e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—B4GALT4—prostate cancer	6.52e-06	8.94e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HPGD—prostate cancer	6.52e-06	8.94e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.52e-06	8.93e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTA1—prostate cancer	6.5e-06	8.91e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NAT2—prostate cancer	6.42e-06	8.81e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTO1—prostate cancer	6.42e-06	8.81e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HSD3B2—prostate cancer	6.42e-06	8.81e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—AKR1C3—prostate cancer	6.36e-06	8.73e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PRKACB—prostate cancer	6.33e-06	8.68e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NCOA2—prostate cancer	6.32e-06	8.66e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP17A1—prostate cancer	6.26e-06	8.59e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.18e-06	8.47e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PLCB2—prostate cancer	6.16e-06	8.44e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—LRP2—prostate cancer	6.16e-06	8.44e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP2C18—prostate cancer	6.16e-06	8.44e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—TNFRSF21—prostate cancer	6.13e-06	8.4e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—P4HB—prostate cancer	6.04e-06	8.28e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SLC5A5—prostate cancer	6.03e-06	8.26e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NCOA2—prostate cancer	5.97e-06	8.18e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—MTAP—prostate cancer	5.96e-06	8.17e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP7B1—prostate cancer	5.96e-06	8.17e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP2E1—prostate cancer	5.89e-06	8.07e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC22A1—prostate cancer	5.88e-06	8.06e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NQO1—prostate cancer	5.82e-06	7.98e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SULT1E1—prostate cancer	5.81e-06	7.97e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SRD5A1—prostate cancer	5.81e-06	7.97e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—TH—prostate cancer	5.74e-06	7.87e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SULT2A1—prostate cancer	5.73e-06	7.85e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC5A5—prostate cancer	5.69e-06	7.81e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP3A4—prostate cancer	5.68e-06	7.78e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—MED12—prostate cancer	5.63e-06	7.72e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GNG5—prostate cancer	5.59e-06	7.66e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP1B1—prostate cancer	5.58e-06	7.65e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP2E1—prostate cancer	5.56e-06	7.63e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ACSL4—prostate cancer	5.54e-06	7.6e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.54e-06	7.6e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NQO1—prostate cancer	5.5e-06	7.54e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—TH—prostate cancer	5.42e-06	7.43e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GGT1—prostate cancer	5.41e-06	7.41e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.39e-06	7.38e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NCOA3—prostate cancer	5.38e-06	7.38e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP3A4—prostate cancer	5.36e-06	7.35e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.34e-06	7.32e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NCOA1—prostate cancer	5.32e-06	7.3e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PHGDH—prostate cancer	5.31e-06	7.29e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—UMPS—prostate cancer	5.31e-06	7.29e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ARG2—prostate cancer	5.31e-06	7.29e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP1B1—prostate cancer	5.27e-06	7.23e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP19A1—prostate cancer	5.25e-06	7.2e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—LDHB—prostate cancer	5.21e-06	7.14e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HPGDS—prostate cancer	5.14e-06	7.04e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP3A5—prostate cancer	5.11e-06	7.01e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GGT1—prostate cancer	5.11e-06	7e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP2C19—prostate cancer	5.1e-06	7e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—RXRA—prostate cancer	5.06e-06	6.94e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NCOA1—prostate cancer	5.03e-06	6.9e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTT1—prostate cancer	4.98e-06	6.83e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ACHE—prostate cancer	4.98e-06	6.83e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP19A1—prostate cancer	4.96e-06	6.8e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PDHA1—prostate cancer	4.94e-06	6.77e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—TCN2—prostate cancer	4.94e-06	6.77e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—UCP3—prostate cancer	4.94e-06	6.77e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTA3—prostate cancer	4.94e-06	6.77e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP2A6—prostate cancer	4.92e-06	6.75e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—COMT—prostate cancer	4.88e-06	6.69e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTP1—prostate cancer	4.86e-06	6.66e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—AKR1C3—prostate cancer	4.79e-06	6.57e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—RXRA—prostate cancer	4.78e-06	6.56e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ITPR1—prostate cancer	4.78e-06	6.55e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PRKACB—prostate cancer	4.76e-06	6.53e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP17A1—prostate cancer	4.71e-06	6.47e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.71e-06	6.46e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.71e-06	6.46e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.65e-06	6.38e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—COMT—prostate cancer	4.61e-06	6.32e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTP1—prostate cancer	4.59e-06	6.29e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTA4—prostate cancer	4.52e-06	6.19e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.52e-06	6.19e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—TYMS—prostate cancer	4.51e-06	6.19e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ITPR1—prostate cancer	4.51e-06	6.19e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NCOA2—prostate cancer	4.49e-06	6.16e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTM1—prostate cancer	4.46e-06	6.12e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.44e-06	6.09e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTA2—prostate cancer	4.4e-06	6.04e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—LPL—prostate cancer	4.38e-06	6.01e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ABCG5—prostate cancer	4.35e-06	5.96e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.35e-06	5.96e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC5A5—prostate cancer	4.29e-06	5.88e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—TYMS—prostate cancer	4.26e-06	5.85e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTA1—prostate cancer	4.25e-06	5.82e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP1A1—prostate cancer	4.23e-06	5.8e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTM1—prostate cancer	4.22e-06	5.78e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.2e-06	5.76e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NAT2—prostate cancer	4.2e-06	5.76e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTO1—prostate cancer	4.2e-06	5.76e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ERCC2—prostate cancer	4.19e-06	5.75e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.19e-06	5.74e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NQO1—prostate cancer	4.14e-06	5.68e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—LPL—prostate cancer	4.14e-06	5.67e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—TH—prostate cancer	4.08e-06	5.59e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.04e-06	5.54e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—LRP2—prostate cancer	4.03e-06	5.52e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.03e-06	5.52e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PLCB2—prostate cancer	4.03e-06	5.52e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP1B1—prostate cancer	3.97e-06	5.44e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ERCC2—prostate cancer	3.96e-06	5.43e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—P4HB—prostate cancer	3.95e-06	5.41e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—MTHFR—prostate cancer	3.94e-06	5.41e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PPARA—prostate cancer	3.87e-06	5.3e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GGT1—prostate cancer	3.84e-06	5.27e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.84e-06	5.27e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NCOA1—prostate cancer	3.79e-06	5.19e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.74e-06	5.13e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP19A1—prostate cancer	3.73e-06	5.12e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—MTHFR—prostate cancer	3.73e-06	5.11e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—MED12—prostate cancer	3.68e-06	5.05e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PPARA—prostate cancer	3.65e-06	5.01e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GNG5—prostate cancer	3.65e-06	5.01e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CAV1—prostate cancer	3.64e-06	4.99e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—RXRA—prostate cancer	3.6e-06	4.94e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NCOA3—prostate cancer	3.52e-06	4.83e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—COMT—prostate cancer	3.47e-06	4.76e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTP1—prostate cancer	3.45e-06	4.73e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CAV1—prostate cancer	3.44e-06	4.71e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ITPR1—prostate cancer	3.4e-06	4.66e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HPGDS—prostate cancer	3.36e-06	4.6e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.34e-06	4.57e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CG—prostate cancer	3.31e-06	4.54e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.28e-06	4.5e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTT1—prostate cancer	3.26e-06	4.47e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ACHE—prostate cancer	3.26e-06	4.47e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.22e-06	4.41e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—TYMS—prostate cancer	3.21e-06	4.4e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTM1—prostate cancer	3.17e-06	4.35e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—INS—prostate cancer	3.14e-06	4.3e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.13e-06	4.29e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CG—prostate cancer	3.13e-06	4.29e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PRKACB—prostate cancer	3.11e-06	4.27e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—LPL—prostate cancer	3.11e-06	4.27e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.08e-06	4.23e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CREBBP—prostate cancer	3.07e-06	4.21e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.01e-06	4.12e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ERCC2—prostate cancer	2.98e-06	4.09e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—INS—prostate cancer	2.96e-06	4.06e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NCOA2—prostate cancer	2.94e-06	4.03e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CD—prostate cancer	2.91e-06	3.99e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CREBBP—prostate cancer	2.9e-06	3.98e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—MTHFR—prostate cancer	2.8e-06	3.84e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.8e-06	3.84e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CD—prostate cancer	2.75e-06	3.77e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PPARA—prostate cancer	2.75e-06	3.77e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NOS3—prostate cancer	2.75e-06	3.77e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.74e-06	3.75e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NQO1—prostate cancer	2.71e-06	3.71e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—TH—prostate cancer	2.67e-06	3.66e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NOS3—prostate cancer	2.6e-06	3.56e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.59e-06	3.56e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CAV1—prostate cancer	2.59e-06	3.55e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CB—prostate cancer	2.54e-06	3.48e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTGS2—prostate cancer	2.52e-06	3.45e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GGT1—prostate cancer	2.51e-06	3.45e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NCOA1—prostate cancer	2.48e-06	3.39e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.44e-06	3.35e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CB—prostate cancer	2.4e-06	3.29e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTGS2—prostate cancer	2.38e-06	3.26e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.36e-06	3.23e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—RXRA—prostate cancer	2.35e-06	3.23e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—COMT—prostate cancer	2.27e-06	3.11e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTP1—prostate cancer	2.26e-06	3.1e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—INS—prostate cancer	2.23e-06	3.06e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ITPR1—prostate cancer	2.22e-06	3.05e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTEN—prostate cancer	2.19e-06	3.01e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CREBBP—prostate cancer	2.18e-06	2.99e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—TYMS—prostate cancer	2.1e-06	2.88e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—EP300—prostate cancer	2.09e-06	2.87e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTM1—prostate cancer	2.07e-06	2.84e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTEN—prostate cancer	2.07e-06	2.84e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.07e-06	2.84e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—LPL—prostate cancer	2.04e-06	2.79e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—EP300—prostate cancer	1.98e-06	2.71e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.97e-06	2.7e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NOS3—prostate cancer	1.96e-06	2.68e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ERCC2—prostate cancer	1.95e-06	2.67e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—MTHFR—prostate cancer	1.83e-06	2.51e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.81e-06	2.48e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PPARA—prostate cancer	1.8e-06	2.47e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTGS2—prostate cancer	1.79e-06	2.45e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CAV1—prostate cancer	1.69e-06	2.32e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTEN—prostate cancer	1.56e-06	2.14e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.55e-06	2.12e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.54e-06	2.11e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—EP300—prostate cancer	1.49e-06	2.04e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CA—prostate cancer	1.46e-06	2e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—INS—prostate cancer	1.46e-06	2e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CREBBP—prostate cancer	1.43e-06	1.96e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.35e-06	1.86e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NOS3—prostate cancer	1.28e-06	1.75e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—AKT1—prostate cancer	1.26e-06	1.73e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—AKT1—prostate cancer	1.19e-06	1.64e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.18e-06	1.62e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTGS2—prostate cancer	1.17e-06	1.6e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.1e-06	1.51e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTEN—prostate cancer	1.02e-06	1.4e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—EP300—prostate cancer	9.73e-07	1.33e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—AKT1—prostate cancer	8.99e-07	1.23e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.19e-07	9.87e-06	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—AKT1—prostate cancer	5.88e-07	8.06e-06	CbGpPWpGaD
